People Who Use Drugs
The Latest
This Week in HIV Research: Removing Barriers to Better Care
Oct. 31, 2019: HCV treatment efficacy regardless of injection drug use; chronic pain, marijuana, and prescription opoids; the most urgent HIV training priorities; neuro effects of switching from Atripla to Complera.
This Week in HIV Research: What's in a Blip?
Aug. 29, 2019: Viral load blips, low-level viremia, and eventual virologic failure; pinpointing non-adherence as a cause of HIV treatment failure; HIV care costs vary widely throughout U.S.; Kaposi sarcoma incidence in the modern HIV treatment era.
This Week in HIV Research: Damming the Cascade of Unmet Needs
Unmet subsistence needs and clinical outcomes; finding HIV treatment success alongside quality-of-life issues; the potential value of facility-level HIV care continuum data; stimulant use and viral suppression.
Continuing Care Needed for HIV-Positive People After Hospitalization for Mental Health Issues
Researchers found that in the 90 days after being hospitalized for mental health issues, HIV-positive people were at increased risk for visits to the emergency department because of substance use disorders and were less likely to receive access to me...
This Week in HIV Research: Where Support Is Lacking, the Virus Can Spread
Housing, social support, and HIV transmissibility among people who use drugs; concerning hepatitis C incidence trends in France; frailty among people aging with HIV; untreated HIV and brain atrophy.
California: UCLA Receives $7 Million Grant to Investigate Links Between Substance Abuse and HIV Among Minority Men
The National Institute on Drug Abuse has awarded $7 million to the University of California, Los Angeles (UCLA), to research the links between substance abuse and HIV among Latino and African-American men who have sex with men (MSM). The research wou...
Case Reports of Complications From Ketamine Use in Two MSM on Ritonavir-Based Combinations
Zhou and colleagues from Brighton and Sussex Hospitals presented a poster detailing two cases of bile duct and liver complications related to recreational use of ketamine.
Both patients had regularly used ketamine for 12 months and were taking riton...
HIV Among Drug Using Populations: A Global Perspective
Transcript (.pdf)
For more information on this session, including access to speaker presentations, please see the conference Programme-at-a-Glance.
The International AIDS Society (IAS) in collaboration with the National Institute on Drug Abuse (NID...
Use of Amphetamines Linked to Cancer
HIV infection, because it weakens the immune system, is linked to an increased risk for the development of certain cancers, including the following:
Kaposi's sarcoma (KS) lymphoma cervical cancer
This cancer risk arises in part because the vari...
HIV-Infected IDUs in the HAART Era Survive in Rates Similar to That of HIV-Negative IDUs
It remains unclear whether HIV-infected injection drug users (IDUs) in the era of highly active antiretroviral therapy (HAART) have durations of survival similar to those for comparable HIV-uninfected IDUs. The aim of the current study was to compare...